MoneyWorks4Me

Alembic Pharmaceuticals informs about updates

15 Jun 2018 Evaluate

Alembic Pharmaceuticals has informed that the Company has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (US FDA) for the inspection carried out by them at the Formulation Facility at Panelav during the period from 12th March, 2018 to 20th March, 2018.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..